Macrogenics (MGNX) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Join SI Premium – FREE
Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.58), $0.01 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $17.04 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber sells part of its Aurora stake in block trade - Bloomberg
- Amylyx Pharmaceuticals (AMLX) 19K contracts trade
- TripAdvisor (TRIP) in the money January 13 puts active
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
